We support researchers whose initiatives align with the mission statement of AMF: To mobilize a community for patient support and advocacy, as well as drive and support impactful research that translates into advances for patients with migraine and other disabling diseases that cause severe head pain.
To help move migraine understanding forward, we have identified several areas that we believe are important to learn more about in an effort to improve the lives of those with migraine:
- Identifying and eliminating the impact of migraine in the workplace
- Improving access to care
- Diversity, Equity, and Inclusion
- Reducing stigma
- Pediatric and adolescent migraine
- Biobehavioral interventions
- Comparative effectiveness studies of migraine therapeutics
How to Submit A Research Request
If you would like to engage our migraine community in your research opportunity, you can submit a request to the American Migraine Foundation team for review.
- Priority will be given to projects that have the potential to have a positive impact on patients quality of life and that may be used to inform medical decision making related to the diagnosis and treatment of migraine and other disabling diseases that cause severe head pain.
- Preference will be given to surveys that will be used to gather meaningful insights from the patient community. These can include questions that would guide clinical trial endpoints, patient preferences, experiential queries, etc.
- Surveys that are part of a trial sponsored by the NIH, PCORI, or other multi-source grant will be given preference.
- Proof of IRB approval (or exemption) must be submitted with survey requests.
- Funding sources (where applicable) must be clearly identified.
- Researchers must submit a letter of inquiry online. There is no charge for submitting a letter of inquiry. If the letter of inquiry is accepted, there is a $100 application fee to submit a full proposal.
- Submissions will be reviewed on a rolling basis and requesters will be notified of AMF’s decision through email.
(ARMR) is pausing activities related to data intake in 2020 and will take this time to analyze and evaluate the insights collected through ARMR since we launched in 2017. Our principal investigators, researchers, clinicians, and patient advocates remain committed to leveraging the information we have received to date to advance the field of headache and migraine. AMF is grateful to the patients, providers, researchers, and its community for supporting this novel effort, and we look forward to the next phase of ARMR.
Please consider supporting the next phase of ARMR with a donation.Donate Now